Reneo Pharmaceuticals (RPHM) Institutional Ownership

$1.76
+0.02 (+1.15%)
(As of 01:16 PM ET)

Institutional Ownership Changes (13F Filings) for Reneo Pharmaceuticals (NASDAQ:RPHM)

Current
Institutional Ownership
Percentage
90.98%
Number of
Institutional Buyers
(last 12 months)
20
Total
Institutional Inflows
(last 12 months)
$29.95M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$69.65K
Get RPHM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Reneo Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RPHM Institutional Buying and Selling by Quarter

Reneo Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/7/2024 Marquette Asset Management LLC73,770$122K0.0%N/A0.221%
5/2/2024 Fifth Lane Capital LP32,635$54K0.0%-18.4%0.098%
4/23/2024 BML Capital Management LLC2,177,913$3.62M2.4%+65.7%6.517%
2/15/2024Octagon Capital Advisors LP2,250,000$3.60M0.6%-1.3%6.754%
2/14/2024Pale Fire Capital SE30,100$48K0.0%+102.7%0.090%
2/14/2024Vestal Point Capital LP400,000$640K0.1%N/A1.201%
2/12/2024Highbridge Capital Management LLC1,121,704$1.80M0.1%N/A3.367%
2/7/2024Jump Financial LLC25,315$41K0.0%N/A0.076%
1/30/2024 BML Capital Management LLC1,314,229$2.10M1.6%N/A3.945%
1/12/2024 SG Americas Securities LLC22,097$35K0.0%N/A0.066%
11/15/2023Adage Capital Partners GP L.L.C.65,000$495K0.0%N/A0.192%
11/14/2023Eventide Asset Management LLC2,078,142$15.83M0.3%+18.8%6.148%
11/14/2023Pale Fire Capital SE14,851$113K0.0%N/A0.044%
11/7/2023Dorsey Wright & Associates3,673$28K0.0%N/A0.011%
11/7/2023Barclays PLC78,118$595K0.0%+5.7%0.231%
10/24/2023 Bank of New York Mellon Corp35,963$274K0.0%+13.1%0.106%
9/8/2023Tucker Asset Management LLC36,753$241K0.1%N/A0.109%
8/14/2023Great Point Partners LLC1,083,317$7.11M1.4%+796.3%3.218%
8/11/2023Franklin Resources Inc.1,345,145$8.82M0.0%+230.0%3.996%
8/11/2023ExodusPoint Capital Management LP555,316$3.64M0.0%+125.9%1.650%
8/4/2023American International Group Inc.4,659$31K0.0%N/A0.014%
8/4/2023 Carlyle Group Inc.2,698,957$17.68M0.6%+30.1%8.019%
8/2/2023MAI Capital Management66,487$436K0.0%+24.4%0.198%
6/1/2023Prelude Capital Management LLC14,800$89K0.0%N/A0.044%
5/16/2023Great Point Partners LLC120,864$723K0.1%N/A0.481%
5/11/2023ExodusPoint Capital Management LP245,787$1.47M0.0%+77.3%0.979%
5/10/2023MAI Capital Management53,428$319K0.0%+96.2%0.213%
5/8/2023Federated Hermes Inc.78,390$469K0.0%-2.0%0.312%
5/5/2023 Carlyle Group Inc.2,073,957$12.24M0.4%N/A8.259%
2/15/2023Tang Capital Management LLC30,587$71K0.0%N/A0.125%
2/9/2023MAI Capital Management27,232$63K0.0%-56.9%0.111%
2/1/2023Bank of Montreal Can33,500$80K0.0%N/A0.137%
11/14/2022Ergoteles LLC37,640$126K0.0%-11.2%0.153%
11/3/2022Barclays PLC71,930$241K0.0%+33.3%0.294%
9/16/2022Federated Hermes Inc.30,000$80K0.0%+76.5%0.123%
5/4/2022Commonwealth Equity Services LLC22,347$65K0.0%N/A0.091%
5/4/2022Tybourne Capital Management HK Ltd.700,000$2.06M0.1%-6.7%2.862%
2/10/2022Qube Research & Technologies Ltd13,482$115K0.0%N/A0.055%
2/8/2022Northern Trust Corp63,547$544K0.0%+7.7%0.260%
2/1/2022Qube Research & Technologies Ltd13,482$115K0.0%N/A0.055%
The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)

A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.

Don't miss out on the "next Ozempic" >>>
11/15/2021Rock Springs Capital Management LP1,143,185$8.52M0.2%+1.3%4.684%
11/15/2021Franklin Resources Inc.450,000$3.35M0.0%-10.0%1.844%
11/9/2021BlackRock Inc.294,281$2.19M0.0%+1.5%1.206%
11/2/2021New York State Common Retirement Fund4,210$31K0.0%-67.6%0.017%
8/17/2021 Caas Capital Management LP20,000$187K0.0%N/A0.082%
8/16/2021California State Teachers Retirement System8,726$81K0.0%N/A0.036%
8/16/2021RA Capital Management L.P.62,217$580K0.0%N/A0.255%
8/16/2021Tudor Investment Corp Et Al13,406$125K0.0%N/A0.055%
8/16/2021Pinz Capital Management LP56,823$530K0.2%N/A0.233%
8/16/2021Charles Schwab Investment Management Inc.13,371$125K0.0%N/A0.055%
8/16/2021State Street Corp60,915$568K0.0%N/A0.250%
8/16/2021Federated Hermes Inc.17,000$159K0.0%N/A0.070%
8/13/2021Northern Trust Corp68,447$639K0.0%N/A0.282%
8/13/2021Franklin Resources Inc.500,000$4.67M0.0%N/A2.059%
8/13/2021Geode Capital Management LLC72,069$672K0.0%N/A0.297%
8/13/2021Vanguard Group Inc.366,210$3.42M0.0%N/A1.508%
8/13/2021FMR LLC187,500$1.75M0.0%N/A0.772%
8/12/2021JPMorgan Chase & Co.7,794$73K0.0%N/A0.032%
8/11/2021RiverVest Venture Management LLC2,409,220$22.48M4.4%N/A9.920%
8/11/2021 Bank of New York Mellon Corp14,837$138K0.0%N/A0.061%
8/11/2021BlackRock Inc.289,824$2.70M0.0%N/A1.193%
8/11/2021Deutsche Bank AG3,745$35K0.0%N/A0.015%
8/10/2021Nicholas Investment Partners LP226,189$2.11M0.1%N/A0.931%
8/6/2021Aisling Capital Management LP886,075$8.27M1.3%N/A3.649%
8/2/2021New York State Common Retirement Fund12,980$121K0.0%N/A0.053%
8/2/2021NEA Management Company LLC4,786,921$44.66M0.6%N/A19.711%
(Data available from 1/1/2016 forward)

RPHM Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RPHM shares?

During the previous two years, 26 institutional investors and hedge funds held shares of Reneo Pharmaceuticals. The most heavily invested institutionals were Carlyle Group Inc. ($17.68M), Eventide Asset Management LLC ($15.83M), Franklin Resources Inc. ($8.82M), Great Point Partners LLC ($7.11M), ExodusPoint Capital Management LP ($3.64M), BML Capital Management LLC ($3.62M), and Octagon Capital Advisors LP ($3.60M).Learn more on RPHM's institutional investors.

What percentage of Reneo Pharmaceuticals stock is owned by institutional investors?

90.98% of Reneo Pharmaceuticals stock is owned by institutional investors. Learn more on RPHM's institutional investor holdings.

Which institutional investors have been buying Reneo Pharmaceuticals stock?

Of the 23 institutional investors that purchased Reneo Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Carlyle Group Inc. ($2.70M), BML Capital Management LLC ($2.18M), Highbridge Capital Management LLC ($1.12M), Great Point Partners LLC ($1.08M), Franklin Resources Inc. ($937.54K), ExodusPoint Capital Management LP ($416.66K), and Vestal Point Capital LP ($400K).

How much institutional buying is happening at Reneo Pharmaceuticals?

Institutional investors have bought a total of 9,583,139 shares in the last 24 months. This purchase volume represents approximately $42.60M in transactions.

Which Reneo Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Reneo Pharmaceuticals stock in the last 24 months: MAI Capital Management ($35.98K), Octagon Capital Advisors LP ($29.87K), Fifth Lane Capital LP ($7.37K), Ergoteles LLC ($4.76K), and Federated Hermes Inc. ($1.61K).

How much institutional selling is happening at Reneo Pharmaceuticals?

Institutional investors have sold a total of 79,583 shares in the last 24 months. This volume of shares sold represents approximately $169.42K in transactions.


This page (NASDAQ:RPHM) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners